Cutaneous adverse drug reactions in a tertiary care hospital

Der Pharmacia Lettre

Volumn 3, Issue 6, 2011, Pages 210-217

  Sudershan, V ^a   Siddiqua, S ^b   Aruna, D ^b   Manmohan, ^b   Ramesh, S ^a   Yasmeen, Nazia ^c  

^a GANDHI MEDICAL COLLEGE   (India)

^b OSMANIA GENERAL HOSPITAL   (India)

^c Shadan College of Pharmacy   (India)

Author keywords

Antimicrobial agents; Cutaneous adverse drug reactions; Fixed drug eruption; Stevens Johnson syndrome

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CEFALEXIN; CEFOTAXIME; CIPROFLOXACIN; COTRIMOXAZOLE; DAPSONE; DICLOFENAC; FOOD ADDITIVE; FURAZOLIDONE; HERBACEOUS AGENT; ISONIAZID; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OFLOXACIN; PHENYTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFADIAZINE; SULFONAMIDE;

ACNE; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG CLASSIFICATION; DRUG HYPERSENSITIVITY; DRUG SURVEILLANCE PROGRAM; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; FEMALE; FIXED DRUG ERUPTION; HOSPITAL PATIENT; HUMAN; LICHENOID ERUPTION; MALE; OUTPATIENT; PEMPHIGUS; PURPURA; SKIN TOXICITY; STEVENS JOHNSON SYNDROME; TERTIARY HEALTH CARE;

EID: 84855381465     PISSN: None     EISSN: 09755071     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. R alf I Edwards, Jaffery K Aronson. Lancet, 2000, 356, 1255-59.
2. Raksha MP, Marfatia YS. Indian J Dermatol venereal Leprol, 2008, 74, 80.
3. The Pharmaceutical Journal London 1999, 262, 357-362
4. De Swarte RD. J Allergy Clin Immunol, 1984, 74, 209-21.
5. Rebecca S Gruchalla. Lancet, 2000, 356, 1505-1511.
6. Middleton E, Reed C, Ellis E, Adkinson NJ, Yunginger J, Busse W. Allergy: principles and practice. St. Louis: Mosby, 1998; vol II, 1212-24.
7. Naldi L, Conforti A, venegoni M, Trancon MG, Caputi A, Ghiotto E, et al. Br J Clin Pharmacol, 1999, 48, 839-46.
8. W Abebe. J Clin Pharmacy & Ther, 2002, 27, 391-401.
9. Stephen E Strauss. N Eng J Med, 2002, 347(25), 1997-1998.
10. Stephens MDB. The diagnosis of adverse medical events associated with drug treatment. Adverse drug React Acute Poisoning Rev, 1987, 1:1-35.
11. Lanctot KL, Naranjo CA. J Clin Pharmacol 1994, 34, 142-147.
12. CA Naranjo, U Busto, Toranto Ontario. Clin Pharmacol Ther, 1981, 30, 239-245.
13. Sharma VK, Sethuraman G, Kumar B. J Post Grad Med, 2001, 47(2), 95-99.
14. Sushma M, Noel MV, Ritika MC, James J, Guidos. Pharmacoepidemiology and Drug Safety, 2005, 14(8), 567-570.
15. Tran C, Knowless SR, Liu BA, Shear NH. J Clin Pharmacol, 1998, 38, 1003-1009.
16. P Mishra, P Subish, S Gupta, PR Shankar, D Bista, AK Chhetri, RB Bhandari. International Journal of Risk and Safety in Medicine, 2006, 18(3), 163-171.
17. Shepherd GM. Immunol Allergy Clin North Am, 1991, 11, 611-13.
18. Kelkar PS, Li JT. N Eng J Med, 2001, 345, 804-809.
19. Wen Yi Ding, Chew Kek Lee. Int J Dermatol, 2010, 49(7), 834-41.
20. John E, Gimnig, John R, Mac Arthur, Maurice M, Bangombe, et al. Am J Trop Med Hyg, 2006, 74(5), 738-743.
21. Beck MH, Portnoy B. Clin Exp Dermatol, 1979, 4, 201-4.
22. Koch-Wesr J, Sidel VW, Dexter M, et al. Arch Int Med, 1971, 128, 399-404.
23. Kauppinens K. Acta Dermatol Venerol (Stokh), 1972, 52, 68.
24. S Ghosh, Leelavathi D Acharya, Padma GM Rao. Indian Journal of Pharmaceutical Sciences, 2006, 68(2), 212-215.
25. Al Ghanem F, Al-Mutairi. Middle east Journal of Emergency Medicine, 2006, 6(2), 11-15.
26. Jimmy Jose, Padme GM, Beena Jimmy. The International Journal of Risk and Safety in Medicine, 2008, 20(3), 169-180.
27. Kishore PV, Subish Palaian, Pradipojha, Shankar PR. Pak J Pharm Sci, 2008, 21(1), 51-56.
28. LY Chang. Cutaneous drug eruption. Hand book of Dermatol & Venerol, 1995, 23, 1-2.
29. Cohen LK, George W, Smith R. Arch Dermatol, 1974, 109, 377-81.
30. Prasad PV. Indian J Dermatol Venerol Leprol, 2001, 67, 69-71.
31. Sweet RD. Lancet, 1950, i, 68.
32. Bork K. Cutaneous side effects of drugs. Philadelphia. WB Saunders 1998.
33. Mohammed MH, Kundlik G, Ranju P, Shahina SS. Der Pharmacia Lettre, 2010, 2(3), 358-368.
34. Ernst. Br J Dermatol, 2000, 143(5), 923-29.
35. Peter Goldman. Ann Int Med, 2001, 135, 594-600.
36. Neuman I, Elian R, Nahum Hetal. J Allergy, 1972, 50, 92-98.
37. Pallock I, Young E, Stoneham M, Slater N, Wilkinson JD, Warner JO. BMJ, 1989, 299, 649-51.
38. Wolkenstein P, Revuz J. Clin Rev Allergy Immunol, 1999, 17, 497-511